D-SNP Medical Coverage Policy: Bioengineered Skin and Soft Tissue Substitute for Breast Reconstruction, Epidermolysis Bullosa Dystrophic (EBD), and Severe Burns

November 03, 2025
group-label
Button Group
size
md
orientation
horizontal
alignment
center
button-type
lh-button
variant
text
text
Blue Medicare
media-label
label
link
Blue Medicare
icon-position
right
full-width
false
full-width-mobile
false
button-type
lh-button
variant
text
text
Medical Policy & Clinical Guidelines
media-label
label
link
Medical Policy & Clinical Guidelines
icon-position
right
full-width
false
full-width-mobile
false
button-type
lh-button
variant
text
text
Claims & Coding
media-label
label
link
Claims & Coding
icon-position
right
full-width
false
full-width-mobile
false

In September 2025, Blue Cross and Blue Shield of North Carolina (Blue Cross NC) implemented a new Medicare Part C Bioengineered Skin and Soft Tissue Substitute for Breast Reconstruction, Epidermolysis Bullosa Dystrophic (EBD), and Severe Burns policy for all Blue Medicare HMO, Blue Medicare PPO, Healthy Blue + Medicare (HMO-POS D-SNP), Blue Medicare Rx members, and members of any third-party Medicare plans supported by Blue Cross NC through administrative or operational services.

Effective January 1, 2026, this policy also applies to Dual Eligible Special Needs Plan (D-SNP) members.

Blue Cross NC is noticing this policy to comply with CMS mandates regarding the Plan implementing internal Medical Policies in the absence of National Coverage Determinations (NCD) or Local Coverage Determinations (LCD) coverage criteria.

Blue Cross NC will provide coverage for Bioengineered Skin and Soft Tissue Substitute for Breast Reconstruction, Epidermolysis Bullosa Dystrophic (EBD), and Severe Burns services when it is deemed medically necessary in accordance with best practice standards, which are detailed within the policy. Please see the full policy, Bioengineered Skin and Soft Tissue Substitute for Breast Reconstruction, Epidermolysis Bullosa Dystrophica (EBD), and Severe Burns, for more information.